The direct and indirect costs of adult atopic dermatitis

BACKGROUND: Atopic dermatitis is considered a childhood illness, and the direct indirect health care burden of atopic in adults not fully understood. OBJECTIVE: To measure costs among 2018. METHODS: This retrospective cohort study compared commercial Medicare-insured with 2018 directly matched (1:3) without dermatitis. prevalence was reported. Health utilization, costs, work loss data were between cohorts. analysis repeated for 2016 2017. RESULTS: 31,164 identified to controls. Adults had greater utilization outpatient services, pharmacy short-term disability benefits than Unadjusted annual $4,979 higher ($14,603) controls ($9,624), driven by services pharmacy. Findings supported analyses from 2017 multivariable analyses. One limitation this that patients mild cases may seek medical treatment be underrepresented cohort. CONCLUSIONS: The (short-term disability) present significant adult population. DISCLOSURES: funded Eli Lilly Company. Employees involved planning, execution, interpretation study. Pierce employed Boytsov Goldblum Company at time research conducted. Manjelievskaia Brouillette are IBM Watson Health, which received funding conduct Bonafede Onyekwere